Sign in
KTTA Stock Price, Chart, Stats & News
Pasithea Therapeutics Corp.
Save
Pasithea Therapeutics Corp. (KTTA) does not currently pay a dividend.
16.04M
Market cap
–
Current P/E
–
Forward P/E
KTTA chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -99.00% |
ROE | -97.88% |
D/E | – |
Interest coverage ratio | – |
KTTA valuation
P/E | – |
P/S | – |
P/B | 0.45x |
P/CF | -0.45x |
P/FCF | -0.45x |
P/OCF | -0.45x |
PEG | -0.02x |
EV multiple | -0.74x |
About
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions.
Similar securities
Based on sector and market capitalization
Report issue